Microangiopathic hemolytic anemia: Difference between revisions
No edit summary |
MydahSajid (talk | contribs) No edit summary |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 12: | Line 12: | ||
}} | }} | ||
{{Microangiopathic hemolytic anemia}} | {{Microangiopathic hemolytic anemia}} | ||
{{CMG}} | {{CMG}} {{AE}} {{MSJ}} | ||
{{SK}} Microangiopathic haemolytic anaemia; MHA | |||
==[[Microangiopathic hemolytic anemia overview|Overview]]== | ==[[Microangiopathic hemolytic anemia overview|Overview]]== | ||
| Line 37: | Line 39: | ||
==Diagnosis== | ==Diagnosis== | ||
[[Microangiopathic hemolytic anemia history and symptoms| History and Symptoms]] | [[Microangiopathic hemolytic anemia physical examination | Physical Examination]] |[[Microangiopathic hemolytic anemia laboratory findings|Laboratory Findings]] | [[Microangiopathic hemolytic | [[Microangiopathic hemolytic anemia history and symptoms| History and Symptoms]] | [[Microangiopathic hemolytic anemia physical examination | Physical Examination]] | [[Microangiopathic hemolytic anemia laboratory findings|Laboratory Findings]] | [[Microangiopathic hemolytic anemia chest x ray|Chest X Ray]] | [[Microangiopathic hemolytic anemia CT|CT]] | [[Microangiopathic hemolytic anemia MRI|MRI]] | [[Microangiopathic hemolytic anemia ultrasound|Ultrasound]] | [[Microangiopathic hemolytic anemia other imaging findings|Other Imaging Findings]] | [[Microangiopathic hemolytic anemia other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[Microangiopathic hemolytic anemia medical therapy|Medical Therapy]] | [[Microangiopathic hemolytic anemia surgery|Surgery]] | [[Microangiopathic hemolytic anemia medical therapy|Medical Therapy]] | [[Microangiopathic hemolytic anemia surgery|Surgery]] | [[Microangiopathic hemolytic anemia primary prevention|Primary Prevention]] | [[Microangiopathic hemolytic anemia secondary prevention|Secondary Prevention]] | [[Microangiopathic hemolytic anemia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Microangiopathic hemolytic anemia future or investigational therapies|Future or Investigational Therapies]] | ||
[[Microangiopathic hemolytic anemia primary prevention|Primary Prevention]] | [[Microangiopathic hemolytic anemia secondary prevention|Secondary Prevention]] | [[Microangiopathic hemolytic anemia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Microangiopathic hemolytic anemia future or investigational therapies|Future or Investigational Therapies]] | |||
==Case Studies== | ==Case Studies== | ||
Latest revision as of 19:58, 30 January 2021
| Microangiopathic hemolytic anemia | |
| ICD-10 | D59.4 |
|---|---|
| ICD-9 | 283.19 |
| DiseasesDB | 29721 |
|
Microangiopathic hemolytic anemia Microchapters |
|
Differentiating Microangiopathic hemolytic anemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Microangiopathic hemolytic anemia On the Web |
|
American Roentgen Ray Society Images of Microangiopathic hemolytic anemia |
|
Directions to Hospitals Treating Microangiopathic hemolytic anemia |
|
Risk calculators and risk factors for Microangiopathic hemolytic anemia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mydah Sajid, MD[2]
Synonyms and keywords: Microangiopathic haemolytic anaemia; MHA
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Microangiopathic hemolytic anemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies